About
Endra Life Sciences Inc (NASDAQ:NDRA) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 25 2026
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
Feb 26 2026
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
Dec 4 2025
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
Nov 20 2025
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
Financials
Revenue
$0
Market Cap
$6.59 M
EPS
-8.93
